CSHL 2022 Microbiome Conference

微生物大会 2022年10月25日至29日 在冷泉港举行的第三届国际微生物组会议 实验室将包括最新的研究探索病因和治疗的广泛 微生物相关疾病，整合临床研究，微生物学， 免疫学、生态学、生物信息学和基因组学。从2019年的前两次会议（在- 人）和2020年（由于COVID虚拟），很明显，CSHL微生物组会议提供了 一个独特的论坛，各种学科聚集在一起，催化新的想法， 综合办法侧重于微生物组在人类健康中发挥的各种作用。的 明确广泛的定义，本次会议的目标微生物组将允许继续 积极参与临床的研究人员开发的思想、技术和理论的相互促进， 生态学和进化论的研究方向。除了把知名的领导人， 发言人说，这次会议将侧重于年轻的研究人员和学员，以促进科学 发展这一领域并开发新的临床和实验 方法、诊断和治疗。会议将深入讨论这两个问题 实验和计算的方法被用来阐明机制， 微生物群落组装，炎症，免疫和传染病。我们将 还探索微生物组在药物反应中的新作用。微生物组研究， 在口头报告中的特色将包括细菌，真菌和病毒相关的疾病， 包括微生物-微生物相互作用。口头和海报会议将侧重于以下主要主题： 微生物组和宿主反应，包括;微生物组的生态学;进化和 微生物组;健康;营养;环境和微生物组;动物模型;还原论者 模型;和技术。会议将包括两个全体主题发言人， 更长的谈话。口头会议将开始与两个邀请会谈，从既定的领导人在 领域，其次是从提交的摘要中选择的6个较短的会谈。包括海报 会议以及分配充足的时间为问题后，每个讲座将鼓励 与会者进行了广泛的讨论。会议将足够小（250 - 350 科学家亲自参加，并有额外的虚拟观众扩大访问），以促进 这些互动，但足够大，以允许年轻的研究人员口头介绍 和那些有着新奇视角的人。微生物组各个方面的整合 研究将成为新的跨学科互动的核心，这将推动这种创新 平移场这次会议将为年轻的研究人员提供独特的机会， 介绍他们的工作和计算，实验和临床学科的融合。

MICROBIOME Conference October 25 – 29, 2022 The third installment of the international Microbiome conference at Cold Spring Harbor Laboratory will include the latest research exploring the etiology and treatment of a wide-range of microbe-associated diseases, integrating the disciplines of clinical research, microbiology, immunology, ecology, bioinformatics and genomics. From the prior two meetings in 2019 (in- person) and 2020 (virtual due to COVID), it was clear that the CSHL Microbiome meeting offers a unique forum where a wide variety of disciplines come together to catalyze new ideas and integrate approaches focused on the varied roles microbiomes play in human health. The explicitly broad definition of microbiomes targeted by this conference will allow for continued mutual fertilization of ideas, techniques and theories developed by researchers active in clinical, ecological and evolutionary lines of research. As well as bringing established leaders as speakers, this meeting will focus on young investigators and trainees to facilitate the scientific interactions necessary to grow this field and develop novel clinical and experimental approaches, diagnostics and therapies. The meeting will provide an in-depth focus on both experimental and computational approaches that are being used to elucidate the mechanisms of microbial community assembly, inflammatory, immunologic and infectious diseases. We will also explore novel roles for the microbiome in drug response. Microbiome studies that are featured in the oral presentations will include bacterial, fungal and viral associated disease, and include microbe-microbe interactions. Oral and poster sessions will focus on major themes of microbiome and the host response, including; Ecology of the Microbiome; Evolution and the Microbiome; Health; Nutrition; Environment and the Microbiome; Animal Models; Reductionist Models; & Technology. The meeting will include two plenary keynote speakers invited to give longer talks. The oral sessions will begin with two invited talks from established leaders in the field, followed by 6 shorter talks chosen from submitted abstracts. The inclusion of poster sessions as well as the allotment of ample time for questions following each talk will encourage extensive discussion between the participants. The meeting will be small enough (250 - 350 scientists attending in-person, with an additional virtual audience to broaden access) to facilitate these interactions, yet large enough to allow for oral presentations from younger investigators and those with novel perspectives. The integration of a wide variety of aspects of microbiome research will nucleate new interdisciplinary interactions that will drive this innovative translational field. This meeting will be distinct in the opportunities for young investigators to present their work and the coalescence of computational, experimental and clinical disciplines.